Welcome to LookChem.com Sign In|Join Free

CAS

  • or

14871-92-2

Post Buying Request

14871-92-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

14871-92-2 Usage

Description

(2,2'-BIPYRIDINE)DICHLOROPALLADIUM(II) is a chemical compound that features a palladium atom coordinated to two chloride ions and two 2,2'-bipyridine ligands. This complex is renowned for its high stability and reactivity, making it a pivotal catalyst in a variety of organic synthesis reactions, especially cross-couplings. Its unique structure, with the 2,2'-bipyridine ligands, enhances the selectivity and versatility of the palladium catalyst, which is instrumental in the synthesis of intricate organic molecules. It has been extensively studied for its potential applications across the pharmaceutical and materials science industries.

Uses

Used in Pharmaceutical Industry:
(2,2'-BIPYRIDINE)DICHLOROPALLADIUM(II) is used as a catalyst in the synthesis of complex organic molecules for pharmaceutical applications. Its high reactivity and selectivity contribute to the efficient production of compounds that are vital in the development of new drugs and medicinal agents.
Used in Materials Science:
In the materials science field, (2,2'-BIPYRIDINE)DICHLOROPALLADIUM(II) is utilized as a catalyst for the synthesis of advanced materials with specific properties. Its role in cross-coupling reactions allows for the creation of materials with tailored characteristics for use in various high-tech applications, such as electronics, optoelectronics, and nanotechnology.
Used in Organic Synthesis:
(2,2'-BIPYRIDINE)DICHLOROPALLADIUM(II) is employed as a catalyst in organic synthesis for the formation of carbon-carbon and carbon-heteroatom bonds. Its presence in cross-coupling reactions facilitates the construction of molecular frameworks that are crucial in the synthesis of natural products, pharmaceuticals, and other organic compounds with biological activity.

Check Digit Verification of cas no

The CAS Registry Mumber 14871-92-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,8,7 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 14871-92:
(7*1)+(6*4)+(5*8)+(4*7)+(3*1)+(2*9)+(1*2)=122
122 % 10 = 2
So 14871-92-2 is a valid CAS Registry Number.

14871-92-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name dichloropalladium,2-pyridin-2-ylpyridine

1.2 Other means of identification

Product number -
Other names 2,2'-BIPYRIDYLPALLADIUM DICHLORIDE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:14871-92-2 SDS

14871-92-2Relevant articles and documents

Multi-target heteroleptic palladium bisphosphonate complexes

Cipriani, Micaella,Docampo, Roberto,Etcheverry, Susana,Gambino, Dinorah,Gancheff, Jorge S.,Kemmerling, Ulrike,Li, Zhu-Hong,Olea Azar, Claudio,León, Ignacio,Otero, Lucía,Rostán, Santiago

, (2020)

Abstract: Bisphosphonates are the most commonly prescribed drugs for the treatment of osteoporosis and other bone illnesses. Some of them have also shown antiparasitic activity. In search of improving the pharmacological profile of commercial bisphosphona

A model study of alternative approach toward a class of palladium(II) based self-assembly

Debata, Niladri Bihari,Ramkumar,Chand, Dillip Kumar

, p. 71 - 78 (2011)

A different approach developed for the preparation of palladium(II) based complexes [(Pd(bpy))x(L)y](NO3) 2x is modelled by using 4-phenylpyridine as ligand (L = 1). Various solvent systems are inspected to opti

Synthesis, Characterization, and Cytotoxicity of Palladium(II) Complexes with Diimine/Diamine and N-Carbonyl-L-Phenylalanine Dianion

Wang, Li-Wei,Liu, Si-Yuan,Wang, Jin-Jie,Peng, Wen,Li, Sheng-Hui,Zhou, Guo-Qiang,Qin, Xin-Ying,Wang, Shu-Xiang,Zhang, Jin-Chao

, p. 1049 - 1056 (2015)

Six palladium(II) complexes, [Pd(bipy)(Bzphe-N,O)] (I-a), [Pd(bipy)(p-Mbzphe-N,O)]·2H2O (I-b), [Pd(bipy)(p-Nbzphe-N,O)]·2H2O (I-c), [Pd(phen)(Bmined by X-ray diffraction. The cytotoxicity test indicates that the complexes exert cytot

Perfluoroalkylation of Square-Planar Transition Metal Complexes: A Strategy to Assemble Them into Solid State Materials with a π-π Stacked Lamellar Structure

Banikhaled, Mohammad O.,Becker, John D.,Koppang, Miles,Sun, Haoran

, p. 1869 - 1878 (2016)

Formation of π-π stacked lamellar structure is important for high performance organic semiconductor materials. We previously demonstrated that perfluoroalkylation of aromatics and heteroaromatics was one of the strategies to design organic crystalline materials with π-π stacked lamellar structures while improving air stability as a result of the strong electron withdrawing ability of perfluoroalkyl substituents. Square-planar transition metal complexes with large π-conjugated ligands are also an important category of semiconductor materials. We have perfluoroalkylated square-planar transition metal complexes, leading to the formation of a π-π stacked lamellar crystal packing motif in the solid state. Here we report six crystal structures of Pd and Pt complexes with bis-perfluorobutylated catechol ligand as one of the two ligands that bonds to the metal centers. This structural design possesses similar molecular topology when compared to perfluoroalkylated aromatics and heteroaromatics we have reported previously, again, demonstrating the steering power of the perfluoroalkyl substituents in engineering organic and organometallic solid state materials.

Mixed neutral compounds of palladium(II) and platinum (II) chelated by diolato(2-) and di-imine ligands

Fox,Gillard

, p. 349 - 352 (1988)

The synthesis and characterization are described for compounds abbreviated (a) 1-5: [Pd(phen)(OO)], where OO = the dianion from 1,2-ethanediol (1), (+)-1,2-propanediol (2), (±)-2,3-butanediol (3), (-)-1,2-butanediol (4), catechol (5); (b) the sulphur analogue (6) [Pd(phen)(SCH2CH2S)], from ethane-1,2-dithiol; (c) the platinum analogue (7) [Pt(phen)(OCH2CH2O)]; (d) the 2,2′-bipyridyl analogue (8), [Pd(bipy)(OCH2CH2O)] (phen = 1,10-phenanthroline and bipy = 2,2′-bipyridyl).

Palladium and platinum complexes of folic acid as new drug delivery systems for treatment of breast cancer cells

He, Chenyang,Heidari Majd, Mostafa,Shiri, Fereshteh,Shahraki, Somaye

, (2021/01/18)

Cisplatin is administrated as an agent in treatment of various cancers by intercalation between DNA strands and inhibition of DNA replication. Among the various factors, two important reasons like inhibition of apoptosis by anti-apoptotic mechanisms and i

Bis(CBT)palladium(II) Derivatives (CBT = m-carborane-1-thiolate): Synthesis, Molecular Structure, and Physicochemical Properties of cis-[(bipy)Pd(CBT)2] and trans-[(py)2Pd(CBT)2]

Amati, Mario,Bellucci, Noemi,Donzello, Maria Pia,Ercolani, Claudio,Ricciardi, Giampaolo,Rizzoli, Corrado,Rosa, Angela,Viola, Elisa

, p. 10478 - 10491 (2021/07/26)

The new synthesized PdII complex cis-[(bipy)Pd(CBT)2] (bipy = 2,2′-bipyridyl; CBT = m-carborane-1-thiolate anion), which is a potential BNCT (boron neutron capture therapy) agent and of structure elucidated by single-crystal X-ray work, has been studied by infrared (IR) and ultraviolet-visible light (UV-vis) spectra and its properties compared with those of the previously reported and also the structurally characterized analogue trans-[(py)2Pd(CBT)2]. This trans species, prepared via a direct method, was previously isolated from a pyridine solution, consequent to the occurring releasing of the external Pd(CBT)2 moieties of the porphyrazine macrocycle [{Pd(CBT)2}4LZn]·xH2O (L = tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato anion), which is an active photosensitizer in photodynamic therapy (PDT) and a potential bimodal PDT/BNCT agent. The UV-vis spectral behavior of both cis and trans species in CHCl3 solution and in the gas phase has been examined in detail by density functional theory (DFT) and time-dependent density functional theory (TDDFT) studies devoted to explain their distinct behavior observed in the region of 400-500 nm, as determined by the presence in the cis structure of a vicinal arrangement of the two CBT groups, an ensemble of results closely similar to those observed for the macrocycles [{Pd(CBT)2}4LM]·xH2O (M = MgII(H2O), ZnII, PdII). It has also been experimentally proved the tendency of the cis isomer in CHCl3/pyridine solution to be changed to the respective trans analogue, with conversion occurring in two steps, as interpreted by detailed DFT studies.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 14871-92-2